18. AIDS Research Center

novel HIV-1 circulating recombinant form (CRF65_cpx)
comprised of CRF01_AE and subtypes B and C in1)

Takebe Y, Naito Y, Raghwani J, Fearnhill E, Sano T,

western Yunnan, China. AIDS Res Hum Retroviruses.

Kusagawa S, Mbisa JL, Zhang H, Matano T, Brown AJ,

30(6): 598-602, 2014.

Pybus OG, Dunn D, Kondo M; UK Collaborative Group2)

KG, Al-Darraji HA, Koh C, Kamarulzaman A, Tee KK:

HIV-1 subtype B associated with transmission amongAmen who have sex with men in Japan. J Virol 88:(CRF58_01B) disseminating among people who inject9864-9876, 2014.

drugs in Malaysia. PLoS One 9(1): e85250, 2014.

Nomura T, Yamamoto H, Takahashi N, Naruse TK,lineage

10) Chow WZ, Nizam S, Ong LY, Ng KT, Chan KG, Takebe

associated with lower viral loads in a macaque AIDS

CRF01_AE, subtype B, and subtype B' identified inmodel. Biochem Biophys Res Commun 450: 942-947,

Malaysia. Genome Announc 2(2), 2014.
11) Zhang W, Han X, An M, Zhao B, Hu Q, Chu Z, Xu J,Terahara K, Ishii H, Nomura T, Takahashi N, Takeda A,Cai W, Chen X, Fu J, Wang Z, Wu J, Lu L, Zhuang M,Shiino

T:Wu H, Yan H, Liao C, Takebe Y, Shang H: Identification

Vaccine-induced CD107a CD4 T cells are resistant toand characterization of a novel HIV-1 circulating

depletion following AIDS virus infection. J Virol 88:

recombinant

14232-14240, 2014.

men-who-have-sex-with-men in China. PLoS One 9(6):Yoshimura K, Harada S, Boonchawalit S, Kawanami Y,e99693, 2014.

T,

Tsunetsugu-YokotaY,Matano+form(CRF59_01B)

identifiedamongand12) Cheong HT, Ng KT, Ong LY, Chook JB, Chan KG,

low-CCR5-adapted mutations induced by in vitro

Takebe Y, Kamarulzaman A, Tee KK: Cross-borderpassage on sensitivity to anti-envelope neutralizing

sexual transmission of the newly emerging HIV-1 clade

antibodies. J Gen Virol 95: 1816-1826, 2014.

CRF51_01B. PLoS One 9(10): e111236, 2014.

S:

Impactofmaraviroc-resistant

Jacob B, Yamamoto N, Brandful JM, Ampofo W,13) Li X, Zang X, Ning C, Feng Y, Xie C, He X, Takebe Y,

Bonney K. Bonney E, Odoom K, Aidoo S, Alale M,Sun L, Guo Q, Xing H, Kalish ML, Shao Y: Molecular

Ntim N, Amoah Y, Ofori S, Ndzinu J, Aziati J, Addo N,

epidemiology of HIV-1 in Jilin province, northeastern

Nyarko A, Ido E, Ishikawa K, Yamaoka S: Establishment

China: emergence of a new CRF07_BC transmissionof in-house quantitative real-time RT-PCR assay forcluster and intersubtype recombinants. PLoS One 9(10):HIV-1 viral load measurement: application to evaluate

e110738, 2014.
14) Imahashi M, Izumi T, Watanabe D, Imamura J,J AIDS Clin Res 5: 305, 2014.

Matsuoka K, Ode H, Masaoka T, Sato K, Kaneko N,Wei H, Hsi JH, Feng Y, Xing H, He X, Liao L, Duan S,

Ichikawa S, Koyanagi Y, Takaori-Kondo A, Utsumi M,

Ning C, Wang N, Takebe Y, Shao Y: Identification of a

Yokomaku Y, Shirasaka T, Sugiura W, Iwatani Y, Naoenovel HIV-1 circulating recombinant form (CRF62_BC)

T:inpolymorphisms of the APOBEC3B gene and HIV-1 risk.

westernYunnanofChina.

AIDSRes

Hum

Retroviruses 30(4): 380-383, 2014.

8)

recombinantof a complex HIV-1 unique recombinant form involving

efficacy of ART in Ghanaian patients in an urban setting.

7)

HIV-1

cell epitopes restricted by a MHC class I haplotypeMatsushita

6)

emerging

Y, Koh C, Kamarulzaman A, Tee KK: Genome sequence+5)

newly

Kimura A, Matano T: Identification of SIV Nef CD8 T2014.

4)

Chow WZ, Takebe Y, Syafina NE, Prakasa MS, Chanon HIV Drug Resistance: Inter-continental dispersal of+3)

9)

Lackofassociation

betweenintact/deletion

PLoS One 9(3): e92861, 2014.

Wei H, Liu Y, Feng Y, Hsi JH, Xing H, He X, Liao L,15) Kudoh A, Takahama S, Sawasaki T, Ode H, Yokoyama

Takebe Y, Li J, Shao Y: Genome sequence of a novel

M, Okayama A, Ishikawa A, Miyakawa K, Matsunaga S,

HIV-1(CRF57_BC)

Kimura H, Sugiura W, Sato H, Hirano H, Ohno S,

identified from Yunnan, China. AIDS Res Hum

Yamamoto N, Ryo A: The phosphorylation of HIV-1

Retroviruses. 30(4): 384-388, 2014.

Gag by atypical protein kinase C facilitates viralFeng Y, Wei H, Hsi JH, Xing H, He X, Liao L, Ma Y,

infectivity by promoting Vpr incorporation into virions.

Ning C, Wang N, Takebe Y, Shao Y: Identification of a

Retrovirology 11: 9, 2014.

circulating

recombinantform

16) Shiino T, Hattori J, Yokomaku Y, Iwatani Y, Sugiura W;

Infect Chemother 21(4): 238-246, 2015.

Japanese Drug Resistance HIV-1 Surveillance Network:24) Chook JB, Ong LY, Takebe Y, Chan KG, Choo M,

Phylodynamic analysis reveals CRF01_AEdisseminationKamarulzaman A, Tee KK: Molecular detection ofbetween Japan and neighboring Asian countries and theHIV-1 subtype B, CRF01_AE, CRF33_01B, and newlyrole of intravenous drug use in transmission. PLoS One

emerging recombinant lineages in Malaysia. Am J Trop

9(7): e102633, 2014.

Med Hyg 92(3): 507-512, 2015.

17) Gu L, Kawana-Tachikawa A, Shiino T, Nakamura H,25) Yoshida S, Hattori J, Matsuda M, Okada K, Kazuyama Y,Koga M, Kikuchi T, Adachi E, Koibuchi T, Ishida T,Hashimoto O, Ibe S, Fujisawa S, Chiba H, Tatsumi M,Gao GF, Matsushita M, Sugiura W, Iwamoto A, Hosoya

Kato S, Sugiura W: Japanese external quality assessment

N: Development and customization of a color-coded

program to standardize HIV-1 drug-resistance testing

microbeads-based assay for drug resistance in HIV-1(JEQS2010 program) using in vitro transcribed RNA asreverse transcriptase. PLoS One 9(10): e109823, 2014.

reference material. AIDS Res Hum Retroviruses 31(3):18) Kusagawa S, Yokota Y, Negishi M, Kondo M, Matano T,318-325, 2015.

Kato S, Takebe Y. Novel HIV-1 recombinant identified

26) Watanabe T, Hamada-Tsutsumi S, Yokomaku Y,

in a foreign heterosexual resident in Japan: relatedness toImamura J, Sugiura W, Tanaka Y: Postexposure

recently reported CRF69_01B, detected primarily amongprophylactic effect of hepatitis B virus (HBV)-active

Japanese men who have sex with men. Genome Announc

antiretroviral therapy against HBV infection. Antimicrob

3: e00196-15, 2015.

Agents Chemothe 59(2): 1292-1298, 2015.

19) Kirby KA, Ong YT, Hachiya A, Laughlin TG, Chiang27) Boonchawalit S, Harada S, Shirai N, Gatanaga H, Oka S,LA, Pan Y, Moran JL, Marchand B, Singh K, Gallazzi F,

Matsushita

Quinn TP, Yoshimura K, Murakami T, Matsushita S,

maraviroc-resistant mutation M434I in the C4 region ofSarafianos SG: Structural basis of clade-specific HIV-1

HIV-1 gp120 on sensitivity to antibody-mediatedneutralization

byhumanizedanti-V3

monoclonal

S,

Yoshimura

K:Impactofneutralization. Jpn J Infect Dis, in press.
28) Sugimoto C, Hasegawa A, Saito Y, Fukuyo Y, Chiu KB,antibody KD-247. FASEB J 29(1): 70-80, 2015.
20) Valdez KPR, Kuwata T, Maruta Y, Tanaka K, Alam M,Cai Y, Breed MW, Mori K, Roy CJ, Lackner AA, Kim

Yoshimura K, Matsushita S: Complementary andWK, Didier ES, Kuroda MJ: Differentiation kinetics ofsynergistic activities of anti-V3, CD4bs and CD4i

blood monocytes and dendritic cells in macaques:

antibodies derived from a single individual can cover ainsights

wide range of HIV-1 strains. Virology 475: 187-203,development. J Immunol, in press.

2015.
21) Matsushita S, Yoshimura K, Valdez KPR, Pisupati J,Murakami T, the KD-1002 Study Group: Passive transferof neutralizing mAb KD-247 reduces plasma viral loadin patients chronically infected with HIV-1. AIDS 29(4):453-462, 2015.
22) Hashimoto M, Nasser H, Bhuyan F, Kuse N, Satou
Y, Harada S, Yoshimura K, Sakuragi J, Monde K, Maeda
Y, Welbourn S, Strebel K, Abd El-Wahab EW, Miyazaki
M, Hattori

S, Chutiwitoonchai

S, Takiguchi

M,SuzuN, Hiyoshi

S: Fibrocytesdiffer

M, Okafrommacrophages but can be infected with HIV-1. JImmunol 195(9):4341-4350, 2015.
23) Takeda S, Hisano M, Komano J, Yamamoto H, Sato H,Yamaguchi K: Influenza vaccination during pregnancy
and its usefulness to mothers and their young infants. Jtounderstandinghuman

myeloidcell